Harvard Bioscience (HBIO) Total Debt Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.63% |
| Dec 31, 2025 | -5.66% |
| Sep 30, 2025 | -4.82% |
| Jun 30, 2025 | -4.43% |
| Mar 31, 2025 | -6.04% |
| Dec 31, 2024 | -7.24% |
| Sep 30, 2024 | -6.97% |
| Jun 30, 2024 | -8.23% |
| Mar 31, 2024 | 85.32% |
| Dec 31, 2023 | -9.67% |
| Sep 30, 2023 | -8.69% |
| Jun 30, 2023 | -7.58% |
| Mar 31, 2023 | -6.90% |
| Dec 31, 2022 | 31.86% |
| Sep 30, 2022 | 26.50% |
| Jun 30, 2022 | 29.73% |
| Mar 31, 2022 | 29.10% |
| Dec 31, 2021 | 24.56% |
| Sep 30, 2021 | 24.62% |
| Jun 30, 2021 | 21.70% |
| Mar 31, 2021 | 17.42% |
| Dec 31, 2020 | 20.71% |
| Sep 30, 2020 | 11.57% |
| Jun 30, 2020 | 16.19% |
| Mar 31, 2020 | 12.78% |
| Dec 31, 2019 | 15.27% |
| Sep 30, 2019 | 18.55% |
| Jun 30, 2019 | 15.00% |
| Mar 31, 2019 | -15.73% |
| Dec 31, 2018 | 15.37% |
| Sep 30, 2018 | 21.04% |
| Jun 30, 2018 | 17.62% |
| Mar 31, 2018 | 33.24% |
| Dec 31, 2017 | -1.93% |
| Sep 30, 2017 | -0.13% |
| Jun 30, 2017 | -3.90% |
| Mar 31, 2017 | -4.06% |
| Dec 31, 2016 | -0.22% |
| Sep 30, 2016 | -1.60% |
| Jun 30, 2016 | -1.13% |
| Dec 31, 2015 | 0.79% |